NexImmune (NASDAQ:NEXI – Get Rating) had its target price boosted by Barclays from $4.00 to $7.00 in a report issued on Friday, The Fly reports. They currently have an overweight rating on the stock. Several other equities analysts have also recently weighed in on the stock. Cantor Fitzgerald reiterated an overweight rating on shares of […]
/PRNewswire/ Considered the meeting place for the life sciences industry in New Jersey, BioNJ s 29th Annual Dinner Meeting & Innovation Celebration will.
/PRNewswire/ Considered the meeting place for the life sciences industry in New Jersey, BioNJ s 29th Annual Dinner Meeting & Innovation Celebration will.